WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 279

Legislative bill overview

SB 279 is a Hawaii bill relating to dangerous drugs that passed the Senate with unanimous support (25-0) in March 2025. The bill was referred to the House Judiciary and Hawaiian Affairs Committee but has been carried over to the 2026 legislative session without further action.

Why is this important

Drug policy legislation directly affects law enforcement practices, criminal penalties, public health approaches, and incarceration rates in Hawaii. The unanimous Senate passage suggests broad bipartisan agreement on the bill's provisions, though the lack of publicly available bill text details means the specific policy direction remains unclear from these records alone.

Potential points of contention

  • Specificity unknown: Without access to the bill's actual text, it's unclear whether it increases penalties, creates treatment alternatives, addresses specific drugs, or implements harm reduction measures—each generating different opposition
  • Implementation costs: Drug policy changes often require new enforcement resources, treatment infrastructure, or administrative capacity that may strain state budgets
  • Equity concerns: Drug legislation historically has disparate impacts on communities of color; stakeholders may debate whether this bill addresses or perpetuates such disparities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.